share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  10/15 08:54

Moomoo AI 已提取核心信息

On October 15, 2024, FOXO Technologies Inc. issued a press release containing a shareholder letter from Interim CEO Mark White, outlining the company's achievements in 2024 and plans for the future. The company, which specializes in epigenetic technology and healthcare, reported two acquisitions expected to generate over $20 million in revenue in 2025 and aims to reach revenues exceeding $50 million annually within the next 12-24 months. FOXO Technologies has expanded its financial management capabilities to ensure SEC compliance and is addressing NYSE American listing requirements deficiencies. The company has also developed a significant patent for a machine learning model that uses DNA epigenetic data to determine biochemical states and medical conditions, which is expected to lead to new health and lifespan solutions. Additionally, FOXO Technologies completed the acquisition of Myrtle Recovery Centers, Inc. and Scott County Community Hospital, Inc., expanding its healthcare services. The company is actively seeking new capital to further grow its business and plans to announce the date for its Annual General Meeting shortly.
On October 15, 2024, FOXO Technologies Inc. issued a press release containing a shareholder letter from Interim CEO Mark White, outlining the company's achievements in 2024 and plans for the future. The company, which specializes in epigenetic technology and healthcare, reported two acquisitions expected to generate over $20 million in revenue in 2025 and aims to reach revenues exceeding $50 million annually within the next 12-24 months. FOXO Technologies has expanded its financial management capabilities to ensure SEC compliance and is addressing NYSE American listing requirements deficiencies. The company has also developed a significant patent for a machine learning model that uses DNA epigenetic data to determine biochemical states and medical conditions, which is expected to lead to new health and lifespan solutions. Additionally, FOXO Technologies completed the acquisition of Myrtle Recovery Centers, Inc. and Scott County Community Hospital, Inc., expanding its healthcare services. The company is actively seeking new capital to further grow its business and plans to announce the date for its Annual General Meeting shortly.
2024年10月15日,FOXO科技公司发布了一份新闻稿,其中包含临时CEO马克·怀特的股东信,概述了公司在2024年的成就和未来计划。这家专注于表观遗传技术和医疗保健的公司报告称,预计2025年将通过两项收购活动实现超过2000万美元的营业收入,并计划在未来12-24个月内实现年营收超过5000万美元。FOXO科技已经扩大了其财务管理能力,以确保符合美国证券交易委员会的规定,并正在解决纽约美国交易所上市的要求不足。该公司还开发了一个重要的专利,用于机器学习模型,该模型利用DNA表观遗传数据来判断生物化学状态和医疗状况,预计将导致新的健康和寿命解决方案。此外,FOXO科技完成了对Myrtle Recovery Centers, Inc.和Scott County Community Hospital, Inc.的收购,扩大了其医疗服务。该公司正在积极寻求新资本,以进一步发展业务,并计划很快宣布年度股东大会的日期。
2024年10月15日,FOXO科技公司发布了一份新闻稿,其中包含临时CEO马克·怀特的股东信,概述了公司在2024年的成就和未来计划。这家专注于表观遗传技术和医疗保健的公司报告称,预计2025年将通过两项收购活动实现超过2000万美元的营业收入,并计划在未来12-24个月内实现年营收超过5000万美元。FOXO科技已经扩大了其财务管理能力,以确保符合美国证券交易委员会的规定,并正在解决纽约美国交易所上市的要求不足。该公司还开发了一个重要的专利,用于机器学习模型,该模型利用DNA表观遗传数据来判断生物化学状态和医疗状况,预计将导致新的健康和寿命解决方案。此外,FOXO科技完成了对Myrtle Recovery Centers, Inc.和Scott County Community Hospital, Inc.的收购,扩大了其医疗服务。该公司正在积极寻求新资本,以进一步发展业务,并计划很快宣布年度股东大会的日期。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息